Research & Clinical Trials
Tumor Treating Fields Showing Early Success for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Oct 23, 2019
Dr. Giovanni Ceresoli doesn’t think Tumor Treating Fields will work for every patient with mesothelioma cancer, but he knows it will work for some. They are in his…
Read More
Effective Second-Line Treatment for Mesothelioma Gaining Ground
- by Tim Povtak
- Research & Clinical Trials
- Oct 17, 2019
Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer.
Read More
Keytruda for Mesothelioma Flops in Phase III Clinical Trial
- by Matt Mauney
- Research & Clinical Trials
- Oct 7, 2019
Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for…
Read More
Mesothelioma Cells Slowed by Grape-Seed Extracts
- by Tim Povtak
- Research & Clinical Trials
- Sep 12, 2019
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest…
Read More
Mesothelioma Clinical Trial Targets Latest Gene Therapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 4, 2019
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may…
Read More
Mesothelioma Study Explores New Treatment When Chemotherapy Fails
- by Tim Povtak
- Research & Clinical Trials
- Aug 26, 2019
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial…
Read More
Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 14, 2019
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I…
Read More
Australian Study Shows Treatment Advances for Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 12, 2019
Patients with peritoneal mesothelioma undergoing a second cytoreductive surgery had a median survival of 92 months, according to a recent study at St. George Hospital and the University of…
Read More
Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Aug 7, 2019
The Baylor College of Medicine in Houston has opened its latest clinical trial for mesothelioma patients to study the effectiveness of a novel immunotherapy combination. The nonsurgical, single-center study…
Read More
Mesothelioma Treatment in Toronto Moves from SMART to SMARTER
- by Tim Povtak
- Research & Clinical Trials
- Jul 31, 2019
The Princess Margaret Cancer Center in Toronto has moved from SMART to SMARTER with the recent launch of its latest clinical trial for pleural mesothelioma patients. SMARTER is the…
Read More
